Balloon Dilation of the Eustachian Tube
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This draft policy governs medical necessity, prior authorization, coverage, and coding for balloon dilation of the eustachian tube (BDET) for Medicare Advantage and Commercial members, including adult and pediatric criteria.
Pediatric indication (ages 8-17) stated as medically necessary when specific criteria are met following FDA expansion and supporting evidence.
Detailed explicit medical necessity criteria for adults including duration of symptoms (>=3 months), required diagnostic testing, failure of medical management, exclusion of other causes, reversibility testing, and contraindications.
CPT codes 69705 and 69706 designated medically necessary for Medicare Advantage Plans and Commercial Products when medical criteria are met.
Statement that evidence is sufficient to determine the technology results in an improvement in the net health outcome.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.